18F-PD-L1 PET/CT in Nivolumab Treated Patients With NSCLC
Clinical trial NCT03564197 · COMPLETED
Trial details
- NCT number
- NCT03564197
- Sponsor
- The Netherlands Cancer Institute
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-25
- Primary completion
- 2025-01-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.